Steven Cohen Kal Vista Pharmaceuticals, Inc. Transaction History

Point72 Asset Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$9.85 - $16.83 $569,330 - $972,773	57,800 New	57,800 $839,000
Q4 2019 Feb 14, 2020	SELL	$10.31 - $17.81 $896,970 - $1.55 Million	-87,000 Closed	0 $0
Q3 2019 Nov 15, 2019	SELL	$11.6 - $21.67 $880,440 - $1.64 Million	-75,900 Reduced 46.59%	87,000 $1.01 Million
Q2 2019 Aug 14, 2019	BUY	$18.44 - $30.89 $3 Million - $5.03 Million	162,900 New	162,900 $3.61 Million

135

52M

551K

98K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $240M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.